Voyager Therapeutics to Host Second Quarter 2016 Investor Update Call

Zafgen Reports Second Quarter 2016 Financial Results

bluebird bio Reports Second Quarter 2016 Financial Results and Recent Operational Progress

CytomX Announces Second Quarter 2016 Financial Results

Editas Medicine Announces Exclusive License to Advanced CRISPR Genome Editing Technology from Massachusetts General Hospital